Wave Life Sciences Ltd. (WVE) — 8-K Filings

8-K Filings (29)

• Wave Life Sciences Files 8-K for Regulation FD Disclosure, Other Events — Mar 26, 2026
  Wave Life Sciences Ltd. filed an 8-K on March 26, 2026, primarily under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). This filing indicates
• Wave Life Sciences Enters Material Definitive Agreement — Dec 11, 2025 Risk: medium
  Wave Life Sciences Ltd. announced on December 9, 2025, that it entered into a material definitive agreement. The company also disclosed information related to R
• 8-K Filing — Dec 8, 2025
• 8-K Filing — Nov 17, 2025
• Wave Life Sciences Files 8-K — Oct 29, 2025 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on October 29, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, Othe
• 8-K Filing — Sep 24, 2025
• Wave Life Sciences Files 8-K — Sep 3, 2025 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on September 3, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, Oth
• Wave Life Sciences Ltd. Files 8-K on Director/Officer Changes — Aug 11, 2025 Risk: medium
  Wave Life Sciences Ltd. filed an 8-K on August 11, 2025, reporting events that occurred on August 5, 2025. The filing indicates changes related to directors and
• 8-K Filing — Aug 5, 2025
• Wave Life Sciences Files 8-K on Financials — Jul 30, 2025 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on July 30, 2025, reporting on its results of operations and financial condition. The filing also includes financial statem
• Wave Life Sciences Files 8-K on Financials — May 8, 2025 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disc
• Wave Life Sciences Files 8-K — Mar 26, 2025 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on March 26, 2025, reporting on other events and financial statements. The filing does not contain specific financial figur
• Wave Life Sciences Files 8-K on Financials — Mar 4, 2025 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on March 4, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD di
• Wave Life Sciences Files 8-K — Jan 13, 2025 Risk: low
  Wave Life Sciences Ltd. reported on January 13, 2025, that its ordinary shares are traded on The Nasdaq Global Market under the ticker symbol WVE. The company i
• Wave Life Sciences Files 8-K — Nov 20, 2024 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on November 20, 2024, reporting under Regulation FD Disclosure and Financial Statements and Exhibits. The filing details th
• Wave Life Sciences Files 8-K on Financials — Nov 12, 2024 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on November 12, 2024, reporting on its Results of Operations and Financial Condition, along with Financial Statements and E
• Wave Life Sciences Files 8-K — Oct 30, 2024 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on October 30, 2024, reporting on various events including Regulation FD disclosures, other events, and financial statement
• Wave Life Sciences Files 8-K — Oct 16, 2024 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on October 16, 2024, reporting on other events and financial statements. The filing does not contain specific details about
• Vertex to Acquire Wave Life Sciences for $3.2B — Oct 15, 2024 Risk: low
  Wave Life Sciences Ltd. announced on October 11, 2024, that it has entered into a definitive agreement to be acquired by Vertex Pharmaceuticals Incorporated for
• Wave Life Sciences Files 8-K — Oct 1, 2024 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on October 1, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain
• Wave Life Sciences Enters Material Definitive Agreement — Sep 26, 2024 Risk: medium
  Wave Life Sciences Ltd. announced on September 25, 2024, that it entered into a material definitive agreement. The company also disclosed information under Regu
• Wave Life Sciences Files 8-K — Sep 24, 2024 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on September 24, 2024, to report on other events and financial statements. The filing does not contain specific details abo
• Wave Life Sciences Ltd. Reports Board Changes and Filings — Aug 12, 2024 Risk: medium
  Wave Life Sciences Ltd. announced on August 6, 2024, a change in its board of directors, with the election of Dr. Paul Bolno and Mr. David Epstein. The company
• Wave Life Sciences Files 8-K on Financials — Aug 8, 2024 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing also includes Regulation FD d
• Wave Life Sciences Files 8-K — Jun 25, 2024 Risk: low
  Wave Life Sciences Ltd. filed an 8-K on June 25, 2024, reporting on other events and financial statements. The filing does not contain specific material events
• Wave Life Sciences Files 8-K on Financials — May 9, 2024 Risk: medium
  Wave Life Sciences Ltd. filed an 8-K on May 9, 2024, reporting on its results of operations and financial condition, along with financial statements and exhibit
• Vertex to Acquire Wave Life Sciences for $1.7B — Mar 6, 2024 Risk: low
  Wave Life Sciences Ltd. announced on March 6, 2024, that it has entered into a definitive agreement to be acquired by Vertex Pharmaceuticals Incorporated for $1
• Wave Life Sciences Files Routine 8-K, No New Material Info — Jan 8, 2024
  Wave Life Sciences Ltd. filed an 8-K on January 8, 2024, indicating a current report under the Securities Exchange Act of 1934. This filing is a routine disclos
• Wave Life Sciences Files 8-K for 'Other Events' on Jan 4, 2024 — Jan 4, 2024
  Wave Life Sciences Ltd. filed an 8-K on January 4, 2024, under the 'Other Events' category. This filing indicates a routine disclosure of information that doesn

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX